Studies of the epidemiology of heart failure in the general population can inform
assessments of disease burden, research, public health policy and health system care …

In the context of precision medicine, disease treatment requires individualized strategies
based on the underlying molecular characteristics to overcome therapeutic challenges …

Background Clinical trials reported the benefit of empagliflozin when combined with
standard treatment relative to cardiovascular death or heart failure (HF) hospitalization in …

Aims The geographic representation of investigators and participants in heart failure (HF)
randomized controlled trials (RCTs) may not reflect the global distribution of disease. We …

Background Adherence to self-care recommendations in heart failure (HF) patients is
essential to improve the patients' quality of life, prevent hospital admission, and reduce …

Ultrasound (US)-based measurements of the inferior vena cava (IVC) diameter are widely
used to estimate right atrial pressure (RAP) in a variety of clinical settings. However, the …

Severe chronic non-communicable diseases (NCDs) pose important challenges for health
systems across Africa. This study explores the current availability of and demand for …

Aims Heart failure (HF) affects an estimated 38 million people worldwide and is the leading
cause of hospitalization among adults and the elderly. Evidence suggests that there may be …

Background: Heart failure is a costly condition with high morbidity and mortality rates in low-
and middle-income countries. Nonadherence to prescribed therapies can lead to severe …

Background Acute decompensated heart failure (ADHF) is a challenging medical
emergency with high mortality and its prevalence is increasing in India. There is paucity of …